[Goals and practical implementation of lipid therapy in coronary heart disease]

Related Experiment Video

Updated: Oct 31, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

F U Beil1, E Windler

  • 1Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg.

Herz
|June 1, 1997
PubMed

Insights

Managing coronary heart disease involves assessing lipid profiles to classify hyperlipidemias. Treatment aims to lower LDL cholesterol, and triglycerides, while increasing HDL cholesterol through diet or medication.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Context:

  • Coronary heart disease (CHD) management necessitates comprehensive lipid profiling.
  • Hyperlipidemia classification is crucial for targeted treatment strategies.

Purpose:

  • To outline the diagnostic and therapeutic approach for lipid management in CHD patients.
  • To define target lipid levels and effective intervention strategies.

Summary:

  • Fasting lipid profiles (total cholesterol, LDL, HDL, triglycerides) are essential for CHD patients.
  • Hyperlipidemias are classified based on elevated LDL cholesterol and/or triglycerides.
  • Treatment goals include LDL cholesterol < 100 mg/dl, HDL cholesterol > 35 mg/dl, and triglycerides < 200 mg/dl.
  • Interventions involve dietary changes and lipid-lowering medications like HMG-CoA reductase inhibitors, bile acid sequestrants, fibrates, or nicotinic acid.

Impact:

  • Establishes clear lipid management goals for CHD patients.
  • Provides a framework for selecting appropriate pharmacotherapies based on lipid profiles.
  • Aims to reduce cardiovascular risk through effective lipid control.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...